>>> US Research Calls

Research Calls I
  • Upgrades:
    • Amicus Therapeutics (FOLD) upgraded to Buy from Neutral at Guggenheim; tgt $13
    • Atmos Energy (ATO) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $132
    • Boston Beer Co (SAM) upgraded to Buy from Hold at Jefferies; tgt raised to $360
    • CG Oncology (CGON) upgraded to Buy from Neutral at Goldman; tgt $50
    • Edison (EIX) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $86
    • Enhabit Inc. (EHAB) upgraded to Market Perform from Underperform at Leerink Partners; tgt $8.50
    • Expeditors Intl (EXPD) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $112
    • Fortrea (FTRE) upgraded to Outperform from Neutral at Robert W. Baird; tgt lowered to $36
    • Fulcrum Therapeutics (FULC) upgraded to Buy from Neutral at Goldman; tgt $15
    • Legacy Housing (LEGH) upgraded to Buy from Neutral at B. Riley Securities; tgt raised to $25
    • Newell Brands (NWL) upgraded to Equal Weight from Underweight at Barclays; tgt $8
    • Planet Fitness (PLNT) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $78
    • Sarepta Therapeutics (SRPT) upgraded to Outperform from Perform at Oppenheimer; tgt $180
    • VTEX (VTEX) upgraded to Overweight from Neutral at JP Morgan; tgt $9
    • Expro Group (XPRO) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $27
  • Downgrades:
    • AirSculpt Technologies (AIRS) downgraded to Market Perform from Outperform at Leerink Partners; tgt lowered to $5
    • Augmedix (AUGX) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $1.50
    • Inotiv (NOTV) downgraded to Hold from Buy at Jefferies; tgt lowered to $3.75
    • Medical Properties Trust (MPW) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $5
    • Oceaneering Intl (OII) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $21
    • RAPT Therapeutics (RAPT) downgraded to Peer Perform from Outperform at Wolfe Research
    • Roblox (RBLX) downgraded to Neutral from Buy at ROTH MKM; tgt lowered to $35
  • Others:
    • Actinum Pharma (ATNM) initiated with a Overweight at Stephens; tgt $25
    • Arcellx (ACLX) initiated with an Outperform at Evercore ISI; tgt $85
    • BioMarin Pharmaceutical (BMRN) initiated with a Outperform at Evercore ISI; tgt $113
    • BioNTech (BNTX) initiated with a In-line at Evercore ISI; tgt $100
    • Blueprint Medicines (BPMC) initiated with a Overweight at Stephens; tgt $140
    • BridgeBio Pharma (BBIO) initiated with an Outperform at Evercore ISI; tgt $50
    • CRH Plc. (CRH) initiated with a Outperform at RBC Capital Mkts; tgt $110
    • CEMEX S.A. (CX) initiated with a Underperform at RBC Capital Mkts; tgt $9
    • Delcath (DCTH) initiated with a Overweight at Stephens; tgt $25
    • Descartes (DSGX) initiated with a Neutral at Redburn Atlantic; tgt $90
    • Elevation Oncology (ELEV) initiated with a Overweight at Stephens; tgt $8
    • Exelixis (EXEL) initiated with an Equal-Weight at Stephens; tgt $23
    • Inovio Pharma (INO) initiated with a Overweight at Stephens; tgt $20
    • Manhattan Assoc (MANH) initiated with a Buy at Redburn Atlantic; tgt $260
    • Moderna (MRNA) initiated with a In-line at Evercore ISI; tgt $120
    • Neurocrine Biosciences (NBIX) initiated with an Outperform at Evercore ISI; tgt $175
    • Blue Owl Capital (OWL) resumed with a Buy at Citigroup; tgt $21
    • Regeneron Pharma (REGN) initiated with an Outperform at Evercore ISI; tgt $1150
    • Seagate Tech (STX) initiated with a Buy at Citigroup; tgt $110
    • Sensei Biotherapeutics (SNSE) initiated with a Overweight at Stephens; tgt $5
    • SPS Commerce (SPSC) initiated with a Buy at Redburn Atlantic; tgt $220
    • Veru (VERU) initiated with a Buy at B. Riley Securities; tgt $5
    • Vermilion Energy (VET) resumed with a Outperform at BMO Capital Markets
    • Weatherford (WFRD) initiated with a Buy at Citigroup; tgt $155
    • Western Digital (WDC) initiated with a Buy at Citigroup; tgt $90

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • STNE -6.9%, BABA -5.2%, IHS -3.1%, PBR -2.1%, LQDA -2%
Other news:
  • NOTV -29.3% (delays 10-Q filing)
  • LLAP -10.5% (selected by LMT for a contract)
  • JAMF -10.4% (commences public offering by selling shareholders)
  • MBIN -7.4% (prices offering of 2.4 mln shares of common stock at $43.00 per share)
  • NGD -4.8% (files mixed shelf)
  • BITF -3.1% (secured an additional 100 MW at its Yguazu site through an amendment to the existing 100 MW Power Purchase Agreement with the Paraguay state-owned utility, ANDE)
  • ATOS -2.1% (files $100 mln mixed shelf)
  • HSAI -2% (CFO resigns; names interim CFO)
  • RXT -1.5% (delays 10-Q filing)
  • RILY -1.3% (delays 10-Q filing)
Analyst comments:
  • OII -1.9% (downgraded to Underweight from Equal Weight at Barclays)

>>> Lionsgate Studios to launch today, Tuesday, May 14

Lionsgate Studios to launch today, Tuesday, May 14
  • Lionsgate (LGF.A, LGF.B) announced that Lionsgate Studios (LION) will launch tomorrow, May 14, as one of the world's largest standalone pure play, publicly-traded content companies when it begins trading as a single class of stock under the NASDAQ ticker symbol LION. Lionsgate Studios is comprised of Lionsgate's Motion Picture Group and Television Studio segments along with a 20,000-plus title film and television library.
  • The transaction, which raised $350 million in proceeds from a group of leading investors, was enabled by a business combination with Screaming Eagle Acquisition Corp. (SCRM), whose shareholders approved the deal at an extraordinary general meeting on May 7, 2024. Screaming Eagle is a publicly-traded special purpose acquisition company established for the purpose of effecting a merger, asset acquisition, or similar business combination with one or more businesses.
  • The transaction is a major step in executing Lionsgate's plan to fully separate its Studio and STARZ businesses. It values Lionsgate Studios at an enterprise value of $4.6 billion.

FT : Anglo American needs a speedy break-up to make up with investors

Anglo American needs a speedy break-up to make up with investors
The fact that the mining group has finally moved to clean up its messy structure has to be a good thing

In tennis, it is known as “spectator’s neck”. The back and forth in BHP’s attempt to win over rival miner Anglo American is enough to make investors rub their napes. Anglo’s latest shot on Tuesday — a break-up plan to focus the group on copper, iron ore and crop nutrients — is worth their attention.

Markets shrugged off Anglo boss Duncan Wanblad’s pledge to create a more profitable, cash flow rich company, with its shares falling slightly as a burgeoning takeover premium deflated. Yet the fact Anglo has finally moved to clean up its messy structure and overly broad commodities mix has to be a good thing.

Wanblad’s restructuring would make Anglo a copper specialist. More than half of its pro forma ebitda would come from the red metal in 2026 on Visible Alpha estimates. He plans to sell off the miner’s metallurgical coal mines, the best of which are in Queensland in Australia, demerge Anglo American Platinum and either divest or demerge the De Beers diamond unit. Anglo’s ailing nickel business will be mothballed.

In met coal, Anglo has plumped for an asset sale that could credibly raise much-needed capital quickly: it is already in contact with buyers for the Australian business in the Bowen Basin. That could raise $3bn; Glencore, for example, has operations not far away.

Other elements will take time. Separating its stake in Johannesburg-listed Amplats will require negotiation, given the large South African labour forces at risk. De Beers may take a while, though Anglo is in advanced talks over a new sales agreement with Botswana, a pre-requisite for any separation. Anglo will probably also seek to sell its stake in Samancor, the South African manganese/chrome business worth about $1.4bn, according to Jefferies.

Simply shedding coal this year would be an important step, given Anglo’s erratic record in executing on previous strategic plans. Those funds should cover a good chunk of any South African tax hit from separating Amplats, as well as paying down some debt. But more importantly this plan should deliver more profits to shareholders. In two years, Wanblad sees better ebitda margins — up by half to 46 per cent. Alone the added $800mn cost savings from this break-up plan once taxed and capitalised is worth $3.5bn, or about £2.30 per share.

Self-help from Anglo is less sexy than an all-out bidding war. But BHP’s constraints on bidding much higher, and the difficulties in going hostile, mean the latter looks increasingly unlikely. Anglo, at least, has given investors reason to stay in their seats.

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • AMC +58%, SPWR +15.3%, HROW +14.3%, PSFE +11.6%, ONON +11.4%, ALLO +5.5%, INFN +5%, LLAP +4.8%, VYGR +4.7%, DDD +4.6%, LBAI +3.8%, VOD +3.4%, PACS +2.9%, STLA +2.4%, STXS +2.3%, SONY +1.9%, IAUX +1.7%, AGYS +1.5%, MPC +1.2%, FTI +1.1%, HCM +0.9%
  • Gapping down:
    • NOTV -33.8%, JAMF -11.5%, MBIN -9.7%, STNE -6.9%, NGD -3.2%, RILY -2.8%, PBR -2%, RXT -1.5%, GROY -1.1%, KOD -0.8%, LQDA -0.7%, U -0.6%

>>> President Biden to increase tariffs on steel, aluminum, semiconductors, EVs,

President Biden to increase tariffs on steel, aluminum, semiconductors, EVs, batteries, solar cells, and some medical equipment (520.91)
  • The tariff rate on certain steel and aluminum products under Section 301 will increase from 0--7.5% to 25% in 2024 (X, NUE, STLD, CLF, AA, CENX, KALU)
  • The tariff rate on semiconductors will increase from 25% to 50% by 2025 (SMH, INTC, AMD, TSM, NVDA)
  • The tariff rate on electric vehicles under Section 301 will increase from 25% to 100% in 2024 (TSLA, NIO, LI, XPEV, BYDDY)
  • The tariff rate on lithium-ion EV batteries will increase from 7.5%% to 25% in 2024, while the tariff rate on lithium-ion non-EV batteries will increase from 7.5% to 25% in 2026. The tariff rate on battery parts will increase from 7.5% to 25% in 2024 (BLNK, CHPT)
  • The tariff rate on natural graphite and permanent magnets will increase from zero to 25% in 2026. The tariff rate for certain other critical minerals will increase from zero to 25% in 2024.
  • The tariff rate on solar cells (whether or not assembled into modules) will increase from 25% to 50% in 2024 (TAN, FSLR, SPWR, CSIQ)
  • The tariff rate on ship-to-shore cranes will increase from 0% to 25% in 2024.
  • The tariff rates on syringes and needles will increase from 0% to 50% in 2024. For certain personal protective equipment (PPE), including certain respirators and face masks, the tariff rates will increase from 0--7.5% to 25% in 2024. Tariffs on rubber medical and surgical gloves will increase from 7.5% to 25% in 2026 (MMM, APT, BDX, CAH)

>>> Europe : Brokers Upgrades & Downgrades - 14th of May 2024 V3(++)

>>> Up
* ADP Raised to Hold at HSBC; PT 135 euros
* EQT Raised to Overweight at JPMorgan; PT 374 kronor
* Ferrovial Raised to Buy at Bestinver; PT 41.05 euros
* Lanxess Raised to Buy at DZ Bank; PT 31 euros
* Mediobanca PT Raised to 16.90 euros at Morgan Stanley
* Nordex Raised to Outperform at Oddo BHF (++)
* OMV Raised to Equal-Weight at Morgan Stanley; PT 46.10 euros
* Poste Italiane PT Raised to 14.80 euros at Morgan Stanley
* Royal Unibrew PT Raised to 680 kroner from 580 kroner at Nordea (+)
* Skan Group Raised to Add at Baader Helvea; PT 87 Swiss francs
* Solwers Raised to Buy at Inderes; PT 5 euros (++)

>>> Down
* Agfa-Gevaert Cut to Accumulate at KBC Securities; PT 2 euros (+)
* Carel Cut to Neutral at Goldman; PT 18.60 euros (++)
* Castellum Cut to Hold at Arctic Securities; PT 140 kronor
* DHL Group Cut to Neutral at BNPP Exane (+)
* Elica Cut to Hold at Intesa Sanpaolo; PT 2.20 euros (++)
* Knorr-Bremse Cut to Sell at Hauck & Aufhaeuser; PT 65.50 euros (+)
* OX2 Cut to Hold at ABG; PT 60 kronor
* OX2 Cut to Hold at Deutsche Bank (+)
* OX2 Cut to Hold at DNB Markets; PT 60 kronor (+)
* Sampo Cut to Reduce at AlphaValue/Baader
* SpareBank 1 SMN Cut to Hold at ABG; PT 153 kroner
* SpareBank 1 Nord Norge Cut to Hold at Arctic Securities (+)
* SpareBank 1 SMN Cut to Hold at Arctic Securities; PT 160 kroner (+)
* Tesco Rated New Buy at Bryan Garnier; PT 349 pence

>>> Initiation
* BioNTech ADRs Rated New Inline at Evercore ISI; PT $100
* Bourse Direct Rated New Buy at TP ICAP Midcap; PT 7.30 euros (+)
* Heidelberg Materials Rated New Outperform at RBC; PT 133 euros
* Holcim Rated New Sector Perform at RBC; PT 91 Swiss francs
* Moderna Rated New Inline at Evercore ISI; PT $120
* Neste Rated New Hold at Deutsche Bank; PT 25 euros (+)
* Svitzer Rated New Sell at SEB Equities; PT 170 kroner
* Svitzer Rated New Buy at Danske Bank Markets; PT 300 kroner (++)
* Svitzer Rated New Outperform at BNPP Exane; PT 325 kroner (++)
* WDP Rated New Buy at Goldman; PT 30.80 euros

>>> Call
* Bayer 1Q Earnings Beat Helped by Crop Science: Jefferies (+)
* Citi’s Montagu Says Bullish Bets on European Stocks Are Rising (+)
* DHL Group Cut at BNPP Exane, High Risk of Profit Warning Ahead (+)
* Holcim Rated New Sector Perform at RBC; Sees Post Split Upside (+)
* JPMorgan’s Kolanovic Says Not Worth ‘Taking on Equity Risk’ Now
* Svitzer Gains as Nordea, Danske Initiate at Buy; SEB Says Sell (++)

Reuters : Anglo CEO says BHP bid forced his hand on demerger of S.Africa assets

Anglo CEO says BHP bid forced his hand on demerger of S.Africa assets

JOHANNESBURG, May 14 (Reuters) - The boss of Anglo American (AAL.L), opens new tab said on Tuesday a bid by rival BHP (BHP.AX), opens new tab to take over the company forced him to accelerate plans for a spin-off of its South Africa's platinum assets, a move set to cause concerns in Pretoria weeks before a national election.

While Anglo was already working on its own review of its assets including the platinum and diamonds businesses, the timeline for the plan had to be speeded up after the approach from BHP, the world's No. 1, Anglo's CEO Duncan Wanblad said.

As a condition for its bid, BHP had requested that Anglo exit its platinum and iron ore units in South Africa.

After rebuffing two proposals from BHP which Anglo said undervalued the company and were too complicated to execute, the London-listed mining giant laid out a strategy that includes a potential break-up of the company by demerging or selling its steelmaking coal, nickel, diamonds and platinum businesses.

As part of the plan, Anglo said it was exploring a demerger of its troubled platinum unit, Johannesburg-listed Amplats, sending its shares down 10%.

"The only thing that the BHP approach did is that it forced the timeline on work that we were already doing," Wanblad said on a conference call after Tuesday's announcement.

"This is an acceleration of a strategy process that we were already executing. I have to say that I would probably not have announced it at this particular point of time."

Shares in Anglo unit Kumba Iron Ore (KIOJ.J), opens new tab were trading about 2.3% higher, reversing earlier losses. Under the strategic review laid out on Tuesday Kumba would stay within the Anglo group.

South Africa holds a national election on May 29, with weak economic growth and high unemployment among the key issues on voters' minds.

>>> Europe : Brokers Upgrades & Downgrades - 14th of May 2024 V2(+)

>>> Up
* ADP Raised to Hold at HSBC; PT 135 euros
* EQT Raised to Overweight at JPMorgan; PT 374 kronor
* Ferrovial Raised to Buy at Bestinver; PT 41.05 euros
* Lanxess Raised to Buy at DZ Bank; PT 31 euros
* Mediobanca PT Raised to 16.90 euros at Morgan Stanley
* OMV Raised to Equal-Weight at Morgan Stanley; PT 46.10 euros
* Poste Italiane PT Raised to 14.80 euros at Morgan Stanley
* Royal Unibrew PT Raised to 680 kroner from 580 kroner at Nordea (+)
* Skan Group Raised to Add at Baader Helvea; PT 87 Swiss francs

>>> Down
* Agfa-Gevaert Cut to Accumulate at KBC Securities; PT 2 euros (+)
* Castellum Cut to Hold at Arctic Securities; PT 140 kronor
* DHL Group Cut to Neutral at BNPP Exane (+)
* Knorr-Bremse Cut to Sell at Hauck & Aufhaeuser; PT 65.50 euros (+)
* OX2 Cut to Hold at ABG; PT 60 kronor
* OX2 Cut to Hold at Deutsche Bank (+)
* OX2 Cut to Hold at DNB Markets; PT 60 kronor (+)
* Sampo Cut to Reduce at AlphaValue/Baader
* SpareBank 1 SMN Cut to Hold at ABG; PT 153 kroner
* SpareBank 1 Nord Norge Cut to Hold at Arctic Securities (+)
* SpareBank 1 SMN Cut to Hold at Arctic Securities; PT 160 kroner (+)
* Tesco Rated New Buy at Bryan Garnier; PT 349 pence

>>> Initiation
* BioNTech ADRs Rated New Inline at Evercore ISI; PT $100
* Bourse Direct Rated New Buy at TP ICAP Midcap; PT 7.30 euros (+)
* Heidelberg Materials Rated New Outperform at RBC; PT 133 euros
* Holcim Rated New Sector Perform at RBC; PT 91 Swiss francs
* Moderna Rated New Inline at Evercore ISI; PT $120
* Neste Rated New Hold at Deutsche Bank; PT 25 euros (+)
* Svitzer Rated New Sell at SEB Equities; PT 170 kroner
* WDP Rated New Buy at Goldman; PT 30.80 euros

>>> Call
* Bayer 1Q Earnings Beat Helped by Crop Science: Jefferies (+)
* Citi’s Montagu Says Bullish Bets on European Stocks Are Rising (+)
* DHL Group Cut at BNPP Exane, High Risk of Profit Warning Ahead (+)
* Holcim Rated New Sector Perform at RBC; Sees Post Split Upside (+)
* JPMorgan’s Kolanovic Says Not Worth ‘Taking on Equity Risk’ Now